Research carried out by RCSI University of Medicine and Health Sciences has revealed new information about how blood clots are formed during wound healing.
The research, published tomorrow in Science Advances, examines the behaviour of platelets at a wound site, specifically their ability to sense where within a blood clot they are and remodel their surroundings accordingly.
Platelets are key to initiating wound healing and the formation of blood clots (thrombus). Fibroblasts are connective tissue cells that are essential for the later stages of wound healing. Fibroblasts invade the clot that has been formed and produce vital proteins, including fibronectin, that then form a structural framework to build the new tissue needed to heal.
This new study indicates that platelets can also form a provisional fibronectin matrix in their surroundings, similar to what fibroblasts do in the later stages of wound healing. This has potential implications for how the integrity of blood clots might be maintained during vascular repair.
The study’s lead author is Dr Ingmar Schoen from the School of Pharmacy and Biomolecular Sciences at RCSI.
Commenting on the discovery, Dr Schoen said: “We have identified an additional unexpected role for the most prominent platelet adhesion receptor. Our results show that platelets not only form the clot but also can initiate its remodelling by erecting a fibrous scaffold. This finding challenges some existing paradigms in the field of wound healing, which is dominated by research on fibroblasts.”
Key to this research was the use of superresolution microscopy, which enables sharper images of structures inside or around cells to be captured and observed in vitro, in a laboratory. Observation of this platelet behaviour in a living organism (in vivo) will be required to further develop this finding.
“Without super-resolution microscopy, this discovery would not have been possible,” Dr Schoen noted.
The research was carried out in collaboration with researchers at ETH Zurich, Julius-Maximilians-University Würzburg, University of Freiburg and University Hospital Zurich.
ENDS
For further information:
Rosie Duffy, Communications Officer, RCSI University of Medicine and Health Sciences
+353 83 302 4611 / rosieduffy@rcsi.ie
Note to editors
RCSI University of Medicine and Health Sciences is a world-leading university for Good Health and Well-being. Ranked second in the world for its contribution to UN Sustainable Development Goal 3 in the Times Higher Education Impact Rankings 2021, it is exclusively focused on education and research to drive improvements in human health worldwide.
RCSI is an international not-for-profit university, headquartered in Dublin. It is among the top 250 universities worldwide in the World University Rankings (2022). RCSI has been awarded Athena Swan Bronze accreditation for positive gender practice in higher education.
Visit the RCSI MyHealth Expert Directory to find the details of our experts across a range of healthcare issues and concerns. Recognising their responsibility to share their knowledge and discoveries to empower people with information that leads them to better health, these clinicians and researchers are willing to engage with the media in their area of expertise.
Journal
Science Advances
DOI
10.1126/sciadv.abj8331
Subject of Research
Cells
Article Title
Platelets drive fibronectin fibrillogenesis using integrin αIIbβ3
Article Publication Date
11-Mar-2022